Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide
2. Ekb 569
3. Ekb-569
4. Eki 569
5. Eki-569
1. 257933-82-7
2. Ekb-569
3. Pelitinib (ekb-569)
4. Way-ekb 569
5. Ekb 569
6. Way-ekb-569
7. 326894-84-2
8. (e)-n-(4-(3-chloro-4-fluorophenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
9. (e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
10. X5dwl380z6
11. (2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide
12. (2e)-n-{4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl}-4-(dimethylamino)but-2-enamide
13. Chebi:38927
14. (e)-n-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
15. Mfcd09837868
16. (e)-n-[4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
17. (e)-n-[4-[(3-chloranyl-4-fluoranyl-phenyl)amino]-3-cyano-7-ethoxy-quinolin-6-yl]-4-(dimethylamino)but-2-enamide
18. 2-butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2e)-
19. Pelitinib [usan]
20. Eki-569
21. Pelitinib [usan:inn]
22. Unii-x5dwl380z6
23. Ekb569
24. Eki 569
25. (2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
26. (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide
27. 93j
28. Pelitinib [inn]
29. Pelitinib (usan/inn)
30. Pelitinib - Ekb-569
31. 2-butenamide, (e)-,
32. Pelitinib [who-dd]
33. Schembl93756
34. Schembl93757
35. Mls006010062
36. Chembl607707
37. Gtpl7644
38. Bdbm31090
39. Cid_6445562
40. Ex-a061
41. Bcpp000118
42. Bcpp000119
43. Zinc602803
44. Bcp02376
45. Nsc729742
46. Nsc800841
47. S1392
48. Akos005146343
49. Ccg-264890
50. Db05524
51. Nsc-729742
52. Nsc-800841
53. Way-172569
54. Ncgc00263103-09
55. Ncgc00263103-10
56. (e)-n-[4-(3-chloro-4-fluoro-anilino)-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide
57. Ac-24700
58. Ac-25029
59. As-16280
60. Hy-32718
61. Smr004701222
62. Pelitinib (ekb-569; Way-ekb 569)
63. P2529
64. Sw219267-1
65. Ec-000.2259
66. D05399
67. 933p827
68. A818030
69. Q-101404
70. Brd-k08799216-001-01-2
71. Q27088290
72. (2e)-n-(-((3-chloro-4-fluorophenyl)amino)3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide
73. (2e)-n-(4-((3-chloro-4-fluorophenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide Pelitinib
74. (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide
75. (e)-n-[3-cyano-4-[(4-fluoro-3-chlorophenyl)amino]-7-ethoxyquinoline-6-yl]-4-(dimethylamino)-2-buteneamide
76. (e)-n-[4-(3-chloro-4-fluoroanilino)-cyano-7-ethoxyquinolin-6-yl]-4-(dimethlyamino)but-2-enamide, (iupac)
77. (e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-dimethylaminobut-2-enamide
78. 3-cyano-4-[(3-chloro-4-fluorophenyl)amino]-6-[[4-(n,n-dimethylamino)-1-oxo-2-buten-1-yl]amino]-7-ethoxyquinoline
79. 4-dimethylaminobut-2-enoic Acid, [4-(3-chloro-4-fluoro Phenylamino)-3-cyano-7-ethoxyquinoline-6-yl]amide
| Molecular Weight | 467.9 g/mol |
|---|---|
| Molecular Formula | C24H23ClFN5O2 |
| XLogP3 | 4.5 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 467.1524308 g/mol |
| Monoisotopic Mass | 467.1524308 g/mol |
| Topological Polar Surface Area | 90.3 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 729 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in colorectal cancer and lung cancer.
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Protein Kinase Inhibitors
Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)
ABOUT THIS PAGE
A Pelitinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pelitinib, including repackagers and relabelers. The FDA regulates Pelitinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pelitinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pelitinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pelitinib supplier is an individual or a company that provides Pelitinib active pharmaceutical ingredient (API) or Pelitinib finished formulations upon request. The Pelitinib suppliers may include Pelitinib API manufacturers, exporters, distributors and traders.
click here to find a list of Pelitinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Pelitinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pelitinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pelitinib GMP manufacturer or Pelitinib GMP API supplier for your needs.
A Pelitinib CoA (Certificate of Analysis) is a formal document that attests to Pelitinib's compliance with Pelitinib specifications and serves as a tool for batch-level quality control.
Pelitinib CoA mostly includes findings from lab analyses of a specific batch. For each Pelitinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pelitinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Pelitinib EP), Pelitinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pelitinib USP).
LOOKING FOR A SUPPLIER?
